Replies to post #2348 on CTI BioPharma Corp (fka CTIC)

[corner]

june 3 p r study released by brown university at the anmerican society for clinical oncology annual meeting cancer patients with cancer of the lower oesophagus had evidence of a complete response to the products phase II proved and offered by ctic .. a phase III should be underway



CTIC HAS AT LEAST TWO HUGE PRODUCTS WINNING PRODUCTS TO GIVE A HIGH RATE OF REMISSION IF NOT FULL REMISSION AND its portfolio is relly impressive

it will not be too long in the near future when the street will recognize the funtastic potential of this company propelling it to AT TLEAST THE PREVIOUS HIGHS